Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease myeloid leukemia
Phenotype C0023418|leukemia
Sentences 33
PubMedID- 24769565 For example, acute promyelocytic leukemia (apl), a subtype of acute myeloid leukemia (aml), has been successfully treated with therapy which utilizes all-trans-retinoic acid (atra).
PubMedID- 25622682 Acute leukemia (al), mainly consisting of acute myeloid leukemia (aml) and acute lymphoblastic leukemia (all), is currently the major cause of death in hematological malignancies, affecting patients of all ages.
PubMedID- 24891015 However, patients with bcr-abl1(+) acute lymphoblastic leukemia and subsets of patients with chronic myeloid leukemia are at high risk of relapse despite kinase inhibition therapy, necessitating novel treatment strategies.
PubMedID- 25196855 The cumulative incidence of emr was 4.0% at 3 years, and the incidence was higher in acute lymphoblastic leukemia patients compared with acute myeloid leukemia patients (5.6% versus 2.4%).
PubMedID- 24744618 Material and methods: the study included 50 leukemia patients (31 with acute myeloid leukemia, 5 with acutelymphoblastic leukemia, 9 with chronic myeloid leukemia, and 5 with chronic lymphocytic leukemia) that underwentpcr-sscp, followed by direct dna sequencing.
PubMedID- 21172090 Continued conduct of studies that include all types of breast cancers is akin to conducting a trial for leukemia where patients with acute myeloid leukemia, acute lymphocytic leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia, and so on, are all eligible for participation.
PubMedID- 25088254 The acute promyelocytic leukemia (apl) subtype of acute myeloid leukemia (aml) is characterized by chromosomal translocations that result in fusion proteins, including the promyelocytic leukemia-retinoic acid receptor, alpha fusion protein (pml-raralpha).
PubMedID- 24876163 Acute promyelocytic leukemia, an aggressive subtype of acute myeloid leukemia, is characterized by the t(15;17) translocation.
PubMedID- 21548944 Seventy-seven newly diagnosed and untreated cases of leukemia, including 24 with acute myeloid leukemia (aml); 14 with chronic phase chronic myeloid leukemia (cml); 18 with t-cell acute lymphocytic leukemia/lymphoma (t-all); 12 with b-cell all (b-all); and nine with b-cell chronic lymphocytic leukemia (b-cll).
PubMedID- 24602197 leukemia-associated aberrant immunophenotype in patients with acute myeloid leukemia: changes at refractory disease or first relapse and clinicopathological findings.
PubMedID- 21343549 Tet2 mutations improve the new european leukemianet risk classification of acute myeloid leukemia: a cancer and leukemia group b study.
PubMedID- 25543705 [chronic lymphocytic leukemia with concomitant chronic myeloid leukemia: a case report].
PubMedID- 20362549 These cells newly evolved from pluripotent leukemia stem cells of chronic myeloid leukemia in the chronic phase.
PubMedID- 25745544 Bone involvement can also rarely occur in acute lymphoblastic leukemia and blast crisis of chronic myeloid leukemia.12 other tumor presenting with predominant bone destruction at this age is ewing’s sarcoma.
PubMedID- 26466808 leukemia stem cells (lscs) of chronic myeloid leukemia (cml) are refractory to tyrosine kinase inhibitor treatment, persist in the residual disease, and are important source for disease recurrence.
PubMedID- 25395751 Acute promyelocytic leukemia (apl), a sub-type of acute myeloid leukemia (aml), is a rare hematological malignancy with an age-dependent incidence.
PubMedID- 22443687 The study proves the concept that curcumin is therapeutically effective against human acute monocytic leukemia, one key type of acute myeloid leukemia.
PubMedID- 24765265 Acute promyelocytic leukemia (apl), m3 subtype of acute myeloid leukemia (aml) is characterized in the majority of cases by proliferation of neoplastic hypergranlar promyelocytes and blast.1 the biological and clinical heterogenicity of apl is based on the clinical presentation of the disease and various characteristics of leukemic cells at diagnosis.
PubMedID- 25797266 M5 leukemia is one subtype of acute myeloid leukemia (aml).
PubMedID- 23226148 Gvt effects can be studied after injecting bn acute myelocytic leukemia cells, a model of human acute myeloid leukemia (martens et al., 1990), into bn recipients (nestvold et al., 2008).
PubMedID- 22541123 [an unusual child case of myeloid/natural killer cell precursor acute leukemia treated successfully with acute myeloid leukemia-oriented chemotherapy].
PubMedID- 22745659 Chromosomal translocations that result in mll (mixed-lineage leukemia)-fusion oncogenes are associated with acute myeloid leukemia (aml), acute lymphoblastic leukemia (all), myelodysplastic syndrome, and secondary therapy-related acute leukemia [1].
PubMedID- 22543830 Philadelphia-negative acute promyelocytic leukemia in a patient with chronic myeloid leukemia in complete cytogenetic response after treatment with tyrosine kinase inhibitor.
PubMedID- 19903674 Background: acute promyelocytic leukemia is a subtype of acute myeloid leukemia characterized by the t(15;17).
PubMedID- 20922786 Tyrosine kinase inhibitor (tki) treatment targeting breakpoint cluster region-abelson murine leukemia virus, the cause of chronic myeloid leukemia (cml), has revolutionized therapy for patients with this disease.
PubMedID- 24522270 Mll-rearranged leukemia is a subset of acute myeloid leukemia (aml) with poor prognosis.
PubMedID- 22184394 Hairy cell leukemia variant in a patient with chronic myeloid leukemia receiving nilotinib: sequential or coincidental.
PubMedID- 20377918 Introduction: the development of philadelphia chromosome (ph) negative acute leukemia/myelodysplastic syndrome (mds) in patients with ph-positive chronic myeloid leukemia (cml) is very rare.
PubMedID- 21393960 Exfoliative dermatitis with leukemia cutis in a patient with chronic myeloid leukemia: a rare association.
PubMedID- 20178013 Among the 114 acute leukemias, 14/63 (22.22%) of the acute myeloid leukemia samples were positive for xage-1b genes.
PubMedID- 22787381 Of note, acute promyelocytic leukemia (apl), a form of acute myeloid leukemia (aml; m3), shows prominently favorable clinical outcomes compared to other types of aml.
PubMedID- 25369030 Acute promyelocytic leukemia (apl), a subtype of acute myeloid leukemia characterized by the formation of a pml-raralpha fusion protein, leads to the accumulation of abnormal promyelocytes.
PubMedID- 20819538 Background: recent studies have shown that interleukin-3 receptor alpha (cd123) is highly expressed on leukemia stem cells of patients with acute myeloid leukemia, and is correlated with tumor load and poor prognosis.

Page: 1